Comparison of poly(acryl starch) and poly(lactide-co-glycolide) microspheres as drug delivery system for a rotavirus vaccine
Authors:
- 1 September 2000
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 68 (3) , 441-450
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Encapsulation of rotavirus into poly(lactide-co-glycolide) microspheresJournal of Controlled Release, 1999
- Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly(d,l-lactide-co-glycolide) microparticlesVaccine, 1999
- Efficacy of the Rhesus Rotavirus–Based Quadrivalent Vaccine in Infants and Young Children in VenezuelaNew England Journal of Medicine, 1997
- Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritisThe Lancet, 1997
- The preparation, characterization and pre-clinical evaluation of an orally administered HIV-I vaccine, consisting of a branched peptide immunogen entrapped in controlled release microparticlesJournal of Controlled Release, 1995
- Enhancement of Rotavirus Immunogenicity by MicroencapsulationVirology, 1994
- Rotavirus vaccine development for the prevention of severe diarrhea in infants and young childrenTrends in Microbiology, 1994
- Comparison of Poly(DL-Lactide-co-Glycolide) and Polystyrene Microsphere Targeting to Intestinal M CellsJournal of Drug Targeting, 1993
- Biodegradable microspheres as a vaccine delivery systemMolecular Immunology, 1991
- Characterization of Polyacryl Starch Microparticles as Carriers for Proteins and DrugsJournal of Pharmaceutical Sciences, 1984